Tom 12, Nr 4 (2018)
Wybrane problemy kliniczne
Opublikowany online: 2018-09-05
Wyświetlenia strony
1901
Wyświetlenia/pobrania artykułu
4811
Mikrokrwotoki mózgowe — nowe oblicze mikroangiopatii mózgowej: obraz kliniczny i aspekty praktyczne
Forum Medycyny Rodzinnej 2018;12(4):127-134.
Streszczenie
Lekarz rodzinny sprawujący systematyczną opiekę nad chorymi w starszym wieku, z postępującym procesem otępiennym, po udarze mózgu oraz wymagających przewlekłego stosowania doustnych leków przeciwpłytkowych, antykoagulantów i statyn, coraz częściej spotyka się w dokumentacji lekarskiej z pojęciem mikrokrwotoki mózgowe (cerebral microbleeds; CMBs). Artykuł pozwala przybliżyć lekarzom rodzinnym najnowszą wiedzę o znaczeniu klinicznym CMBs oraz poznać najnowsze zalecenia i rekomendacje towarzystw naukowych, w odniesieniu do prowadzenia terapii w ostrych incydentach sercowo-naczyniowych oraz profilaktyki wtórnej udaru mózgu u chorych z wcześniej wykrytymi CMBs.
Słowa kluczowe: mikrokrwotoki mózgowerezonans magnetycznyleczenie udaru mózgudoustne leczenie przeciwkrzepliwe
Referencje
- Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry. 2008; 79(9): 1002–1006.
- Vernooij MW, Lugt Av, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study. Neurology. 2008; 70(14): 1208–1214.
- Janaway BM, Simpson JE, Hoggard N, et al. MRC Cognitive Function and Ageing Neuropathology Study. Brain haemosiderin in older people: pathological evidence for an ischaemic origin of magnetic resonance imaging (MRI) microbleeds. Neuropathol Appl Neurobiol. 2014; 40(3): 258–269.
- Poels MMF, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010; 41(10 Suppl): S103–S106.
- Greenberg SM, Vernooij MW, Cordonnier C, et al. Microbleed Study Group. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009; 8(2): 165–174.
- Ayaz M, Boikov AS, Haacke EM, et al. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging. 2010; 31(1): 142–148.
- Kakar P, Charidimou A, Werring DJ. Cerebral microbleeds: a new dilemma in stroke medicine. JRSM Cardiovasc Dis. 2012; 1(8): 2048004012474754.
- Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013; 12(5): 483–497.
- Wardlaw JM, Smith EE, Biessels GJ, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12(8): 822–838.
- Fisher M. The challenge of mixed cerebrovascular disease. Ann N Y Acad Sci. 2010; 1207: 18–22.
- Fisher M, Vasilevko V, Cribbs DH. Mixed cerebrovascular disease and the future of stroke prevention. Transl Stroke Res. 2012; 3(Suppl 1): 39–51.
- Soo YOY, Yang SR, Lam WWM, et al. Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds. J Neurol. 2008; 255(11): 1679–1686.
- Boulanger JM, Coutts SB, Eliasziw M, et al. VISION Study Group. Cerebral microhemorrhages predict new disabling or fatal strokes in patients with acute ischemic stroke or transient ischemic attack. Stroke. 2006; 37(3): 911–914.
- Benedictus MR, Prins ND, Goos JD, et al. Microbleeds, Mortality, and Stroke in Alzheimer Disease: The MISTRAL Study. JAMA Neurol. 2015; 72(5): 539–545.
- Charidimou A, Shams S, Romero JR, et al. International META-MICROBLEEDS Initiative. Clinical significance of cerebral microbleeds on MRI: A comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1). Int J Stroke. 2018; 13(5): 454–468.
- Charidimou A, Shoamanesh A, Al-Shahi Salman R, et al. Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach. Int J Stroke. 2018; 13(2): 117–120.
- Charidimou A, Kakar P, Fox Z, et al. Cerebral microbleeds and the risk of intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2013; 84(3): 277–280.
- Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2014; 45(10): 2900–2905.
- Powers WJ, Rabinstein AA, Ackerson T, et al. American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018; 49(3): e46–e4e110.
- Kozera G, Sobolewski P, Serafin Z. (red.). Doświadczenie dwóch dekad leczenia trombolitycznego udaru niedokrwiennego mózgu. Aktualne pytania i odpowiedzi. AstriaMed, Gdańsk 2017.
- van der Vlies AE, Goos JDC, Barkhof F, et al. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology. 2012; 79(8): 763–769.
- Goos JDC, Teunissen CE, Veerhuis R, et al. Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease. Neurobiol Aging. 2012; 33(5): 1011.e1–1011.e9.
- Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke. 2005; 36(7): 1588–1593.
- Vernooij MW, Haag MDM, van der Lugt A, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009; 66(6): 714–720.
- Gregoire SM, Jäger HR, Yousry TA, et al. Brain microbleeds as a potential risk factor for antiplatelet-related intracerebral haemorrhage: hospital-based, case-control study. J Neurol Neurosurg Psychiatry. 2010; 81(6): 679–684.
- Ge L, Niu G, Han X, et al. Aspirin treatment increases the risk of cerebral microbleeds. Can J Neurol Sci. 2011; 38(6): 863–868.
- Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke. 1995; 26(8): 1471–1477.
- Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology. 2009; 72(2): 171–176.
- Ueno H, Naka H, Ohshita T, et al. Association between cerebral microbleeds on T2*-weighted MR images and recurrent hemorrhagic stroke in patients treated with warfarin following ischemic stroke. AJNR Am J Neuroradiol. 2008; 29(8): 1483–1486.
- Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014; 383(9921): 955–962.
- Diener HC, Selim MH, Molina CA, et al. Embolic stroke, atrial fibrillation, and microbleeds: is there a role for anticoagulation? Stroke. 2016; 47(3): 904–907.
- Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.
- Smith EE, Saposnik G, Biessels GJ, et al. American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Council on Hypertension. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017; 48(2): e44–e71.
- Jauch EC, Saver JL, Adams HP, et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Peripheral Vascular Disease, Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013; 44(3): 870–947.
